Predictive value of tissue factor bearing microparticles in cancer associated thrombosis

被引：49
作者：
Zwicker, Jeffrey I. [1 ]
机构：
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Cambridge, MA 02138 USA
来源：
THROMBOSIS RESEARCH | 2010年 / 125卷
关键词：
Cancer associated thrombosis; Microparticles; Venous thromboembolic events; FACTOR EXPRESSION; COLORECTAL-CANCER; PANCREATIC-CANCER; P-SELECTIN; IN-VIVO; ANGIOGENESIS; COAGULATION; CELLS; THROMBOEMBOLISM; ACTIVATION;
D O I：
10.1016/S0049-3848(10)70022-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Venous thromboembolic events (VTE) are a common complication of cancer and its therapy. Prognostic models and biomarkers are currently under investigation as a means to identify cancer patients who are at greatest risk for developing thromboembolic complications and thus are most likely to benefit from primary thromboprophylaxis. Elevations in circulating tissue factor bearing microparticles are associated with thrombosis in cancer patients. We initiated the MicroTEC study which is a randomized, multi-center trial to evaluate the benefit of low molecular weight heparin to prevent VTE in high risk cancer patients. This review details the evidence for tissue factor bearing microparticles in the malignant state and its association with thromboembolic phenomena. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码：S89 / S91
页数：3
相关论文
共 16 条
[1]  
BASTIDA E, 1984, BLOOD, V64, P177
[2]   Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation [J].
Chou, J ;
Mackman, N ;
Merrill-Skoloff, G ;
Pedersen, B ;
Furie, BC ;
Furie, B .
BLOOD, 2004, 104 (10) :3190-3197
[3]  
DVORAK HF, 1983, CANCER RES, V43, P4334
[4]   Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin [J].
Falati, S ;
Liu, QD ;
Gross, P ;
Merrill-Skoloff, G ;
Chou, J ;
Vandendries, E ;
Celi, A ;
Croce, K ;
Furie, BC ;
Furie, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (11) :1585-1598
[5]   Tissue factor-positive microparticles: Cellular origin and association with coagulation activation in patients with colorectal cancer [J].
Hron, Gregor ;
Kollars, Marietta ;
Weber, Heinz ;
Sagaster, Verena ;
Quehenberger, Peter ;
Eichinger, Sabine ;
Kyrle, Paul A. ;
Weltermann, Ansgar .
THROMBOSIS AND HAEMOSTASIS, 2007, 97 (01) :119-123
[6]   Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer [J].
Khorana, A. A. ;
Francis, C. W. ;
Menzies, K. E. ;
Wang, J. -G. ;
Hyrien, O. ;
Hathcock, J. ;
Mackman, N. ;
Taubman, M. B. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (11) :1983-1985
[7]   Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer [J].
Khorana, Alok A. ;
Ahrendt, Steven A. ;
Ryan, Charlotte K. ;
Francis, Charles W. ;
Hruban, Ralph H. ;
Hu, Ying Chuan ;
Hostetter, Galen ;
Harvey, Jennifer ;
Taubman, Mark B. .
CLINICAL CANCER RESEARCH, 2007, 13 (10) :2870-2875
[8]  
Shoji M, 1998, AM J PATHOL, V152, P399
[9]   Microparticle-associated tissue factor activity: a link between cancer and thrombosis? [J].
Tesselaar, M. E. T. ;
Romijn, F. P. H. T. M. ;
Van der Linden, I. K. ;
Prins, F. A. ;
Bertina, R. M. ;
Osanto, S. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (03) :520-527
[10]   Microparticle-associated tissue factor activity in cancer patients with and without thrombosis [J].
Tesselaar, M. E. T. ;
Romijn, F. P. H. T. M. ;
van der Linden, I. K. ;
Bertina, R. M. ;
Osanto, S. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (08) :1421-1423
12